Company / Total Assets
Amneal Pharmaceuticals, Inc. Total Assets History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Assets
$3.7B
FY2025
5-year range
$3.5B / $3.9B
FY2021-FY2025
Trend
+5.1%
vs FY2024
Sector context
#29 of 214
Health Care
What the data says
Amneal Pharmaceuticals, Inc.'s total assets of $3.7B is higher than 86% of companies in the Health Care sector (FY2025). Total Assets has fluctuated over the past 9 years, ranging from $1.3B in FY2017 to $4.4B in FY2018.
Based on SEC 10-K filings.
$3.7B in FY2025 with a 5-year CAGR of -1.7%. Top quartile in the Health Care sector.
Improved from $3.5B to $3.7B over the past 2 years.
Health Care sector context is included.
Total Assets over time
Growth rates
- 3-Year CAGR
- -1.1%
- 5-Year CAGR
- -1.7%
- 10-Year CAGR
- -
Sector benchmark
Top 14% in Health CareTop 14% of 214This company $3.7B Sector average $7.5B
▼
-50.8% below sector average
Key checks
Key Insights
- 5-year CAGR of -1.7%, indicating a declining trend.
- In FY2025, total assets increased 5.1% year-over-year.
- Ranks #29 out of 214 companies in the Health Care sector.
- Peak total assets was recorded in FY2018.
Company context
Key Data Points
- Altman Z-Score 1.22 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $3.7B | +5.1% |
| FY2024 | $3.5B | +0.8% |
| FY2023 | $3.5B | -8.6% |
| FY2022 | $3.8B | -3.6% |
| FY2021 | $3.9B | -1.7% |
| FY2020 | $4.0B | +9.3% |
| FY2019 | $3.7B | -15.8% |
| FY2018 | $4.4B | +224.4% |
| FY2017 | $1.3B | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026